Novartis
NVS
NVS
918 hedge funds and large institutions have $22.3B invested in Novartis in 2014 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 335 increasing their positions, 320 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.05% more ownership
Funds ownership: 9.72% → 9.77% (+0.05%)
1% less capital invested
Capital invested by funds: $22.5B → $22.3B (-$272M)
13% less funds holding in top 10
Funds holding in top 10: 71 → 62 (-9)
Holders
918
Holding in Top 10
62
Calls
$183M
Puts
$76.9M
Top Buyers
| 1 | +$71.9M | |
| 2 | +$63.8M | |
| 3 | +$53.3M | |
| 4 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$51.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$45.9M |
Top Sellers
| 1 | -$107M | |
| 2 | -$88M | |
| 3 | -$76.8M | |
| 4 |
SCCM
Schafer Cullen Capital Management
New York
|
-$68.5M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$53.8M |